Vision therapy marketing: dyslexia and ADHD claims

Vision therapy sits in a crowded and contested corner of eye care. Parents find it while searching for help with a child who hates reading, loses their place on the page or gets headaches after homework. Some of those children have a treatable eye teaming or focusing problem. Others have a reading disability or attention problem that eye exercises will not touch. A vision therapy practice that markets well tells those groups apart on its own pages, and keeps its claims to what the evidence supports.

Two related topics have their own guides and are not repeated here. Eye exams, optical sales, recalls and Business Profiles for an optometry office are covered in our optometry marketing ideas, and marketing evaluations for attention and developmental concerns is covered in our ADHD and autism evaluation marketing guide. This guide covers what is specific to vision therapy. If your practice also advertises eye exams, glasses or contacts, read our guide to the Contact Lens Rule and Eyeglass Rule for eye care ads and offers.

This is general information, not legal or medical advice. Scope of practice for optometrists and orthoptists is set state by state, plans write their own coverage rules, and clinical questions belong with your clinicians. Sources cited were checked on October 30, 2026: the joint statement Learning Disabilities, Dyslexia, and Vision of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, the American Academy of Ophthalmology and the American Association of Certified Orthoptists (reaffirmed 2014), the AAPOS glossary entry Vision Therapy (updated April 2023), the National Eye Institute page Convergence Insufficiency (last updated December 4, 2024), the NEI research news release of October 23, 2019 on the CITT-ART trial, the NIMH page on ADHD (last reviewed August 2026), 15 U.S.C. 45 and 52, the FTC Health Products Compliance Guidance, 16 CFR 255.2, 16 CFR 312.3, 45 CFR 164.502 and 164.508 and the Google Ads restricted targeting policy for personalized advertising.

Know where the evidence lines are

The professions that care for children’s eyes do not describe vision therapy the same way, and a parent reading your site may already have read the other side. The glossary entry on vision therapy from the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) says the term is used by optometrists, and separates three kinds: behavioral or perceptual vision therapy, vision therapy aimed at myopia, and orthoptic exercises for how the two eyes work together. It says orthoptic exercises can be helpful for eye movement problems that cause blurry vision, double vision or headaches, such as convergence insufficiency. It also says “Behavioral vision therapy has not been proven by science to work,” and that there is no evidence vision therapy slows myopia or helps it get better.

The joint statement on learning disabilities, dyslexia and vision from the American Academy of Pediatrics, AAPOS, the American Academy of Ophthalmology and the American Association of Certified Orthoptists, published in Pediatrics in August 2009 and reaffirmed in 2014, says vision problems can interfere with learning, “however, vision problems are not the cause of primary dyslexia or learning disabilities.” It goes on: “Diagnostic and treatment approaches that lack scientific evidence of efficacy, including eye exercises, behavioral vision therapy, or special tinted filters or lenses, are not endorsed and should not be recommended.”

The National Eye Institute gives the other half of the picture. Its page on convergence insufficiency names vision therapy as the treatment, describes it as convergence exercises with a specialist and at home, and notes that prism glasses can be used and that surgery is an option in rare cases. It says a child can have perfect vision and still have convergence insufficiency, which a regular eye exam will not catch, and that it can take 12 weeks or more to notice a change.

A practice that markets vision therapy is on solid ground when it describes the treatment of a diagnosed binocular vision or focusing problem. It is on weak ground when it presents vision therapy as a treatment for reading disability, learning disability, attention problems or myopia.

Dyslexia, reading and learning claims

The trial with the clearest bearing on marketing copy was funded by NEI and run by eye care researchers. NEI’s October 23, 2019 news release on the CITT-ART trial reports that children aged 9 to 14 with symptomatic convergence insufficiency were randomly assigned to 16 weeks of in-office vision therapy or placebo therapy. Vision therapy improved clinical measures of how the eyes worked together, but there was no difference between the groups in reading improvement. The lead author, an optometrist, is quoted: “While in-office vision therapy can improve visual function for children with CI, this trial indicates that clinicians should not suggest that it will lead to increased reading performance.”

The joint statement says the same from the other side: “Treating convergence insufficiency can make reading more comfortable but does not improve the decoding or understanding of reading.” It also says letter reversals are not part of the definition of dyslexia. AAPOS adds that reading problems in children with dyslexia are not caused by an eye tracking issue.

Those sources make these headlines hard to defend:

“Vision therapy for dyslexia” or “we treat dyslexia” on a page or ad.
“Raise reading levels” or “better grades in [number] weeks.”
“Is your child’s learning disability really a vision problem?”
“Stop letter reversals” presented as a sign of a vision problem you treat.
Colored lenses or overlays offered as help for reading or learning disabilities.
“Slow your child’s myopia with vision therapy.”

Claims like these are health claims. 15 U.S.C. 45 prohibits unfair or deceptive acts or practices, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of devices or services. The FTC staff Health Products Compliance Guidance says its aim is to help ensure that claims about the benefits and safety of health-related products are truthful, not misleading and supported by science, that the same legal principles apply to the marketing of any health-related product, and that health benefit claims require competent and reliable scientific evidence. A claim that vision therapy improves reading or learning would need that evidence, and the trial results above point the other way.

ADHD and attention claims

Trouble concentrating is one of the symptoms of convergence insufficiency on the NEI page, alongside tired or sore eyes, blurry or double vision and headaches. That overlap is where “fixes ADHD” copy comes from, and it is not support for that copy. A child who loses focus during close work because of eye strain has a vision symptom. A child with ADHD has a separate condition with its own evaluation and treatment.

The National Institute of Mental Health page on ADHD lists the standard treatments as medication and psychosocial interventions, such as cognitive behavioral therapy, parent training and school interventions. Vision therapy is not on that list. Leave out “ADHD or vision problem?” quizzes, “natural alternative to ADHD medication” lines and any copy that suggests a child can stop medication after vision therapy. Wording that fits: “If your child’s eyes tire, blur or double during close work, an eye exam can check for an eye teaming problem. Attention concerns need their own evaluation with your child’s doctor.”

Pages that describe what you treat

Strong vision therapy pages lead with the diagnosis, not the hoped-for school result. List what your practice evaluates and treats:

Convergence insufficiency and other eye teaming problems, with the symptoms NEI names: tired or sore eyes, blurry or double vision and headaches during close work.
Focusing problems at near, described in plain words.
Vision symptoms after a concussion or brain injury, as part of care your patient’s physician also directs. NEI notes convergence insufficiency can happen at any age after a brain injury.
What the evaluation involves, and that it goes beyond a standard eye chart test.
What treatment involves: office visits, home exercises, and any prism glasses, with the time NEI says it can take to notice a change.
When you refer: to a pediatric ophthalmologist for strabismus or other findings, and to the child’s doctor or school for learning or attention concerns.

That last point builds trust with the referral sources you need. The joint statement recommends that children with suspected learning disabilities be referred early for educational, psychological, neuropsychological or medical assessment. A vision therapy page that says “we check your child’s eyes; if we find no eye problem that explains the symptoms, we will tell you and point you to the right next step” reads as honest to a pediatrician and to a parent.

Writing for parents

The person reading your page is a worried parent, and the page should help them decide without pressure. Avoid fear lines such as “Don’t let a hidden vision problem ruin your child’s school years.” Do not promise a set number of sessions or a date by which a child will improve. State the program length as a range your clinicians set after the evaluation, and say how progress is measured and reported.

Parent testimonials need the same care as any endorsement. Under 16 CFR 255.2, an advertiser may not use a consumer endorsement that conveys a performance claim the advertiser could not substantiate if it made the claim directly. A parent quote saying “his reading jumped two grade levels” or “she no longer needs her ADHD medication” makes a claim your practice could not make itself. A quote about headaches easing during homework, if true for that child, stays inside what the evidence supports for diagnosed convergence insufficiency.

Using a child’s name, photo or story in marketing needs written HIPAA authorization under 45 CFR 164.508(a)(3). Under 45 CFR 164.502(g), a parent or guardian who has authority to act for a minor in health care decisions is treated as the minor’s personal representative, with exceptions set out in that paragraph, so in the ordinary case the parent signs. Older children deserve a say too: ask them as well, and drop the story if they do not want it shared.

Children’s privacy, forms and ad targeting

Write your site, quizzes and forms for parents, not for the child. 16 CFR 312.3, part of the FTC’s children’s online privacy rule, makes it unlawful for an operator of a website or online service directed to children, or one with actual knowledge that it is collecting personal information from a child, to collect that information in a way that violates the rule. A game or symptom checker built for kids to fill in themselves brings you into that rule. A symptom checklist addressed to the parent keeps you out of it.

Symptom answers about a child’s reading, attention or headaches are sensitive once tied to a name or email. Keep them out of ad and analytics tools. Our guide to tracking pixels on practice websites explains how those tools can pass form data to ad platforms.

Google’s policy on restricted targeting in personalized advertising lists Health among its sensitive interest categories. Build campaigns around the terms parents search, such as convergence insufficiency treatment or vision therapy near a city, rather than audiences based on health interests or your patient list. Avoid ad copy that implies you know the reader’s child has a condition. Marketing for children’s services in general is covered in our pediatric practice marketing guide.

Coverage and prices

Coverage for vision therapy depends on the plan. Medical plans and vision plans write their own rules on whether binocular vision treatment is covered, which diagnoses qualify and whether prior authorization is needed. Do not write “covered by insurance” on a page. Say that your staff will check the family’s plan before treatment starts and explain what the plan covers and what the family would pay. If you sell programs as packages, describe what the package includes and the refund terms, and do not tie the package to an outcome.

Illustration: two ads for the same program

Illustration: a practice runs an ad that reads “Struggling reader? It may be their eyes! Our vision therapy helps kids with dyslexia and ADHD read better and focus in school. Results in 12 weeks. Covered by insurance.” It links vision therapy to dyslexia and ADHD, promises a school outcome on a deadline, and makes a coverage claim it cannot support for every family.

Illustration: the practice rewrites it as “[Practice name] Vision Therapy: Does your child get headaches, blurry or double vision during homework? We test eye teaming and focusing at near, which a standard eye chart test may miss. We check your plan before treatment. Call [phone].” It names symptoms the NEI lists, describes the evaluation, and promises nothing about reading or attention.

Checklist before a vision therapy campaign goes live

Service pages lead with diagnosed eye teaming and focusing problems, described in the terms NEI uses.
No page or ad says vision therapy treats dyslexia, learning disabilities, ADHD or myopia, or improves reading scores or grades.
No colored lens or overlay is offered as help for reading or learning disabilities.
Pages say when you refer to a pediatric ophthalmologist, the child’s doctor or the school.
Program length is a range set after evaluation, with no outcome tied to a session count or package.
Parent testimonials make no reading, school or medication claims, and each story has a signed authorization.
Quizzes and forms are written for parents, and their answers stay out of ad and analytics tools.
Ads target search terms, not health interests or patient lists, and make no coverage promise.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For a vision therapy practice, that means service pages that explain eye teaming and focusing problems in plain words for parents, search content around the symptoms parents notice, and inquiry forms that keep a child’s health information away from tracking tools. We do not decide clinical, scope or coverage questions; your clinicians and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Can a vision therapy practice advertise that it helps children with dyslexia?

Not as a treatment claim. The joint statement of the pediatric and ophthalmology groups says vision problems are not the cause of primary dyslexia or learning disabilities, and an NEI-funded trial found that treating convergence insufficiency did not improve reading scores more than placebo therapy.

Can we say vision therapy treats convergence insufficiency?

Yes, with care. The National Eye Institute names vision therapy, in the form of convergence exercises, as the treatment for convergence insufficiency and says it can take 12 weeks or more to notice a change. Describe the diagnosis and the program, not a school outcome.

Can we market vision therapy for ADHD?

No. Trouble concentrating can be a symptom of convergence insufficiency, but the NIMH lists medication and psychosocial interventions as standard ADHD treatments. Tell parents that attention concerns need their own evaluation.

Can we say vision therapy slows myopia?

AAPOS says there is no evidence that vision therapy slows the progression of myopia or helps it get better. Leave that claim out unless you have competent and reliable scientific evidence for it.

Can we share a parent’s story about their child?

With written HIPAA authorization, signed by the parent or guardian acting for the child, and without reading, school or medication claims your practice could not support if it made them directly.

Can we say vision therapy is covered by insurance?

Not as a general statement. Coverage depends on the plan. Say that your staff will check the family’s plan before treatment and explain what it covers.

Sources

More in Dental, vision, hearing and therapy marketing

Vision therapy marketing: dyslexia and ADHD claims, convergence insufficiency and parents as the audience